Anuh Pharma Profit & Loss Annual

BSE: 506260 | NSE: - | ISIN: INE489G01022 | Sector: Biotechnology & Drugs

199.75 +4.85 (2.49%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	647.00	527.49	486.65	431.96
Total Revenue	647.00	527.49	486.65	431.96
Costof Revenue Total	486.66	401.48	377.68	329.80
Gross Profit	160.34	126.00	108.97	102.16
Selling/ General/ Admin Expenses Total	19.39	62.35	52.01	49.38
Depreciation/ Amortization	8.58	9.70	11.96	15.08
Other Operating Expenses Total	65.80	10.03	8.41	8.19
Total Operating Expense	580.44	483.57	450.06	402.45
Operating Income	66.57	43.92	36.59	29.51
Interest Inc( Exp) Net- Non- Op Total	-3.54	34.72	24.25	86.57
Other Net	12.10	0.06	0.05	0.38
Net Income Before Taxes	78.31	47.47	39.12	38.55
Provisionfor Income Taxes	18.25	11.29	8.56	10.12
Net Income After Taxes	60.06	36.18	30.56	28.44
Net Income Before Extra Items	60.06	36.18	30.56	28.44
Net Income	60.06	36.18	30.56	28.44
Income Availableto Com Excl Extra Ord	60.06	36.18	30.56	28.44
Income Availableto Com Incl Extra Ord	60.06	36.18	30.56	28.44
Diluted Net Income	60.06	36.18	30.56	28.44
Diluted Weighted Average Shares	5.01	5.01	5.01	5.01
Diluted EPS Excluding Extra Ord Items	11.98	7.22	6.10	5.67
DPS- Common Stock Primary Issue	2.50	2.00	1.75	1.50
Diluted Normalized EPS	11.98	7.22	6.09	5.67
Gain( Loss)on Saleof Assets	-	0.15	0.62	0.00